Skip to main content
logo
Shukra Pharmaceuticals Limited (BOM:524632)
India flag India · Delayed Price · Currency is INR
31.71
-0.01 (-0.03%)
At close: Jul 27, 2026

Shukra Pharmaceuticals Cash Flow Statement

Millions INR. Fiscal year is Apr - Mar.

Operating Activities

Fiscal Year
FY 2026FY 2025FY 2024FY 2023FY 2022
Period Ending
Mar '26 Mar '25 Mar '24 Mar '23 Mar '22
Net Income
220.5895.75185.3744.077.51
Depreciation & Amortization
34.4330.0520.518.3816.62
Other Operating Activities
44.84-8.852.21-4.50.8
Change in Accounts Receivable
-141.81157.4656.74-227.8623.47
Change in Inventory
-39.5-76.398.427.97-22.72
Change in Accounts Payable
8.4919.95-261.51260.9732.61
Change in Other Net Operating Assets
-87.72-138.79-63.7-67.3321.6
Operating Cash Flow
39.3179.18-51.9731.779.89
Operating Cash Flow Growth
-50.35%---60.32%1386.79%

Investing Activities

Fiscal Year
FY 2026FY 2025FY 2024FY 2023FY 2022
Period Ending
Mar '26 Mar '25 Mar '24 Mar '23 Mar '22
Capital Expenditures
-157.3-27.43-17.6-44.91-15.5
Investment in Securities
-----0.09
Other Investing Activities
15.8714.795.590.640.31
Investing Cash Flow
-141.43-12.64-12.01-44.27-15.28

Financing Activities

Fiscal Year
FY 2026FY 2025FY 2024FY 2023FY 2022
Period Ending
Mar '26 Mar '25 Mar '24 Mar '23 Mar '22
Long-Term Debt Issued
0.84.56-6.42-
Long-Term Debt Repaid
---11.12--63.94
Net Debt Issued (Repaid)
0.84.56-11.126.42-63.94
Issuance of Common Stock
--138.7246.28-
Common Dividends Paid
-4.38-43.79-0.7-0.73-
Other Financing Activities
44.28-5.95-2.85-2.56-2.81
Financing Cash Flow
40.7-45.18124.0549.41-66.75

Net Cash Flow

Fiscal Year
FY 2026FY 2025FY 2024FY 2023FY 2022
Period Ending
Mar '26 Mar '25 Mar '24 Mar '23 Mar '22
Miscellaneous Cash Flow Adjustments
0-0--
Net Cash Flow
-61.4121.3760.0836.84-2.15

Free Cash Flow

Fiscal Year
FY 2026FY 2025FY 2024FY 2023FY 2022
Period Ending
Mar '26 Mar '25 Mar '24 Mar '23 Mar '22
Free Cash Flow
-117.9951.75-69.57-13.2264.39
Free Cash Flow Growth
-----
Free Cash Flow Margin
-20.80%15.88%-9.33%-2.22%31.43%
Free Cash Flow Per Share
-0.270.12-0.16-0.201.03
Levered Free Cash Flow
-137.7432.25-123.17-43.5257.98
Unlevered Free Cash Flow
-130.9135.51-121.45-41.9259.74

Additional Metrics

Fiscal Year
FY 2026FY 2025FY 2024FY 2023FY 2022
Period Ending
Mar '26 Mar '25 Mar '24 Mar '23 Mar '22
Cash Interest Paid
9.645.952.852.562.81
Cash Income Tax Paid
16.2237.626.252.54.37
Change in Working Capital
-260.54-37.77-260.05-26.2454.96